agilon health (AGL) CTO receives 28,000-share RSU grant and tax withholding entry

Rhea-AI Filing Summary

agilon health, inc. Chief Technology Officer Venkatachaliah Girish reported routine equity compensation and related tax withholding in company stock. On April 1, 2026, he received a grant of 28,000 shares of Common Stock, described as restricted stock units that vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment. On the same date, 480 shares at $9.75 per share were withheld by the issuer solely to satisfy income tax obligations in connection with the net settlement of restricted stock units and do not represent a sale. Following these transactions, his beneficial ownership increased to 38,662 shares, which the disclosure notes reflects a 1-for-25 reverse stock split of the company’s common stock effective March 30, 2026.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Venkatachaliah Girish

Role Chief Technology Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	480	$9.75	$5K
Grant/Award	Common Stock	28,000	$0.00	--

Holdings After Transaction: Common Stock — 10,662 shares (Direct)

Footnotes (1)

1. Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026. Restricted stock units that vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment. Includes restricted stock units.

Key Figures

RSU grant: 28,000 shares Tax withholding shares: 480 shares Withholding price: $9.75 per share +2 more

5 metrics

RSU grant 28,000 shares Restricted stock units granted on April 1, 2026

Tax withholding shares 480 shares Shares withheld to satisfy income tax obligations

Withholding price $9.75 per share Value used for 480 tax-withholding shares

Post-transaction holdings 38,662 shares Beneficial ownership after reported transactions

Reverse stock split ratio 1-for-25 Reverse split of common stock effective March 30, 2026

Key Terms

restricted stock units, reverse stock split, net settlement, income tax withholding

4 terms

restricted stock units financial

"Restricted stock units that vest in three equal installments on each anniversary of April 1, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

reverse stock split financial

"reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock"

A reverse stock split is when a company reduces the number of its shares outstanding, making each share more valuable. For example, if you own 100 shares worth $1 each, a 1-for-10 reverse split would turn your 100 shares into 10 shares worth $10 each. Companies often do this to boost their stock price and appear more stable to investors.

net settlement financial

"in connection with the net settlement of the restricted stock units and does not represent a sale"

income tax withholding financial

"withheld by the issuer to satisfy its income tax withholding and remittance obligations"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Venkatachaliah Girish

(Last) (First) (Middle)

C/O AGILON HEALTH, INC.

440 POLARIS PARKWAY, SUITE 550

(Street)

WESTERVILLE OHIO 43082

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
agilon health, inc. [ AGL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		F		480(1)	D	$9.75	10,662(2)	D
Common Stock	04/01/2026		A		28,000(3)	A	$0	38,662(4)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.

2. The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.

3. Restricted stock units that vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment.

4. Includes restricted stock units.

Remarks:

	/s/ Mimi Yang, as Attorney-in-Fact	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did agilon health (AGL) CTO report on April 1, 2026?

The CTO reported a grant of 28,000 shares of Common Stock as restricted stock units and the withholding of 480 shares for taxes. These are compensation-related entries, not open-market purchases or sales.

Was the agilon health (AGL) CTO’s Form 4 transaction a stock sale?

No. The Form 4 states 480 shares were withheld by the issuer to cover income taxes on restricted stock units. The filing explicitly notes this does not represent a sale of shares into the market.

How many agilon health (AGL) shares does the CTO own after these transactions?

After the reported transactions, the CTO beneficially owns 38,662 shares of Common Stock, including restricted stock units. The filing notes this amount reflects a 1-for-25 reverse stock split effective March 30, 2026.

How do the new restricted stock units for agilon health (AGL) CTO vest?

The restricted stock units granted on April 1, 2026 vest in three equal installments on each anniversary of April 1, 2026. Vesting is subject to continued employment, aligning the CTO’s compensation with long-term service.

What was the price used for the tax withholding shares in the agilon health (AGL) Form 4?

The 480 shares withheld for tax obligations were valued at $9.75 per share. This withholding covers income tax liabilities arising from the net settlement of vested restricted stock units awarded to the CTO.

How did agilon health’s reverse stock split affect the CTO’s reported holdings?

The filing notes the CTO’s 38,662 shares after the transaction reflect a 1-for-25 reverse stock split of the company’s common stock effective March 30, 2026, consolidating previously outstanding shares into fewer shares.